Mrdovic IB - Search Results

1

Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions.

Antonijevic NM, Zivkovic ID, Jovanovic LM, Matic DM, Kocica MJ, Mrdovic IB, Kanjuh VI, Culafic MD. Antonijevic NM, et al. Among authors: mrdovic ib. Curr Drug Metab. 2017;18(7):622-635. doi: 10.2174/1389200218666170427113504. Curr Drug Metab. 2017. PMID: 28460624 Review.

2

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.

Perunicic J, Antonijevic NM, Miljic P, Djordjevic V, Mikovic D, Kovac M, Djokic M, Mrdovic I, Nikolic A, Vasiljevic Z. Perunicic J, et al. J Thromb Thrombolysis. 2008 Oct;26(2):142-6. doi: 10.1007/s11239-007-0076-y. Epub 2007 Sep 9. J Thromb Thrombolysis. 2008. PMID: 17828468

3

The long-term risk of stroke in patients with acute myocardial infarction complicated with new-onset atrial fibrillation.

Asanin MR, Vasiljevic ZM, Matic MD, Mrdovic IB, Perunicic JP, Matic DP, Vujisic-Tesic BD, Stankovic SD, Matic DM, Ostojic MC. Asanin MR, et al. Among authors: mrdovic ib. Clin Cardiol. 2009 Aug;32(8):467-70. doi: 10.1002/clc.20603. Clin Cardiol. 2009. PMID: 19685521 Free PMC article.

4

Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.

Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, Antonijevic N, Kocev N, Marinkovic J, Vasiljevic Z, Ostojic M. Mrdovic I, et al. Coron Artery Dis. 2012 Jan;23(1):1-8. doi: 10.1097/MCA.0b013e32834df552. Coron Artery Dis. 2012. PMID: 22107800 Clinical Trial.

5

The usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Stankovic S, Asanin M, Majkic-Singh N, Ignjatovic S, Mihailovic M, Nikolajevic I, Mrdovic I, Matic D, Savic L, Marinkovic J, Ostojic M, Vasiljevic Z. Stankovic S, et al. Clin Lab. 2012;58(1-2):125-31. Clin Lab. 2012. PMID: 22372355

6

Time-dependent changes of myeloperoxidase in relation to in-hospital mortality in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Stankovic S, Asanin M, Trifunovic D, Majkic-Singh N, Ignjatovic S, Mrdovic I, Matic D, Savic L, Marinkovic J, Ostojic M, Vasiljevic Z. Stankovic S, et al. Clin Biochem. 2012 May;45(7-8):547-51. doi: 10.1016/j.clinbiochem.2012.02.015. Epub 2012 Feb 28. Clin Biochem. 2012. PMID: 22394459

7

B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Asanin M, Stankovic S, Mrdovic I, Matic D, Savic L, Majkic-Singh N, Ostojic M, Vasiljevic Z. Asanin M, et al. Peptides. 2012 May;35(1):74-7. doi: 10.1016/j.peptides.2012.02.022. Epub 2012 Mar 6. Peptides. 2012. PMID: 22421508

8

Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.

Mrdovic I, Savic L, Krljanac G, Asanin M, Perunicic J, Antonijevic N, Lasica R, Marinkovic J, Kocev N, Vasiljevic Z. Mrdovic I, et al. Int J Cardiol. 2013 Aug 20;167(4):1632-7. doi: 10.1016/j.ijcard.2012.04.129. Epub 2012 May 22. Int J Cardiol. 2013. PMID: 22626838 Clinical Trial.

9

Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Stankovic S, Asanin M, Trifunovic D, Majkic-Singh N, Miljković A, Ignjatovic S, Mrdovic I, Matic D, Savic L, Ostojic M, Vasiljevic Z. Stankovic S, et al. Clin Lab. 2012;58(11-12):1135-44. Clin Lab. 2012. PMID: 23289182

10

Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention.

Matic DM, Milasinovic DG, Asanin MR, Mrdovic IB, Marinkovic JM, Kocev NI, Marjanovic MM, Antonijevic NM, Vukcevic VD, Savic LZ, Zivkovic MN, Mehmedbegovic ZH, Dedovic VM, Stankovic GR. Matic DM, et al. Among authors: mrdovic ib. Heart. 2014 Jan;100(2):146-52. doi: 10.1136/heartjnl-2013-304564. Epub 2013 Oct 31. Heart. 2014. PMID: 24179161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page